Navigation Links
Listing on Frankfurt Stock Exchange for CTI (http://ctinanotech.com)
Date:11/3/2010

LOS ANGELES, Nov. 3, 2010 /PRNewswire/ -- CTI (OTC Bulletin Board: CVAT, Berlin & Stuttgart: WTC) proudly announces that its common shares are now also listed on the Frankfurt Stock Exchange under the ticket symbol WTC.

CTI's CEO Roman Gordon stated: "We hope to achieve another milestone with the listing on the Frankfurt Stock Exchange to help with our long term focus...this listing should help us gain visibility and support in the European market.  The listing on the Frankfurt exchange will increase the profile of CTI with both private and institutional investors in Germany and across Europe.  This opportunity to broaden our shareholder base comes at an excellent time for our company as we move into the next phase of our corporate initiative."

Mike Gorodnitsky, President of CTI added: "European investors have a strong interest for investing in 'Green-Tech' companies.  Particularly our relationship with Desmet Ballestra (http://www.desmetgroup.com), a large conglomerate with its headquarters in Europe, specializing in the engineering and refining processes for edible and other oils will help expose and introduce our technology throughout the world."

Next to trading in the U.S., and the German exchanges in Berlin and Stuttgart, the Frankfurt Stock Exchange may help CTI build a better investor foundation to move forward.  The Frankfurt Stock Exchange provides full-service trading capabilities, which include a trading floor as well as an electronic trading exchange, XETRA.

About the Frankfurt Stock Exchange

The Frankfurt Stock Exchange, known as the Frankfurter Wertpapierenboerse (FWB) is one of the world's largest trading centers for securities.  Operated by the Deutsche Boerse AG, FWB is the largest of the eight Germany stock exchanges.  The Deutsche Boerse's products and services portfolio cover the entire process chain including securities and deriva
'/>"/>

SOURCE CTI
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
2. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
3. PLC Systems Receives Delisting Notice From American Stock Exchange
4. EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
5. Nasdaq Grants VirtualScopics Request for Continued Listing
6. Memory Pharmaceuticals Provides Update on NASDAQ Listing Status
7. Memory Pharmaceuticals Granted Extension to Comply with NASDAQ Listing Requirements
8. Spherix Transfers Stock Listing to Nasdaq Capital Market
9. NYSE Alternext US Accepts China Shenghuos Compliance Plan for Continued Listing
10. Interleukin Genetics Receives Notification of Failure to Meet Continued Listing Standard Section 1003(a)(iii)
11. BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 19, 2014  Roche (SIX: RO, ROG; OTCQX: ... Inc. (Bina), a privately held company based in ... Bina provides a big data platform for centralized ... data. Bina,s proprietary on-market Genomic Management Solution, Bina-GMS ... to perform fast and scalable analyses to maximize ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 ... nation’s leading specialty pharmacies, has an expanded team ... clinical pharmacy consultants for prescriber offices in their ... , “We have a variety of Regional ... example, those specializing in hepatitis C help prescribers ...
(Date:12/19/2014)... Reports from CDC show approximately 117 ... or more chronic health conditions - including cardiovascular disease, ... of these diseases, but may not eliminate the severe ... implanted nerve stimulation devices today offer relief, they require ... induce side effects. , To eliminate the need ...
(Date:12/19/2014)... San Diego, CA (PRWEB) December 18, 2014 ... announces a limited time special on Sartorius Biohit ... 1 Free on mLINE pipettes, Picus Electronic Pipette Trade-in ... recommended by Health and Safety officers around the world. ... repetitive manual pipetting. Other features include:, , ...
Breaking Biology Technology:Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2
... System Offers Healthcare Workers Consistent Cleaning , ... , IRVINE, Calif., Dec. 16 ... the availability of the EVOTECH(TM) Endoscope Cleaner and ... labor-intensive manual cleaning of endoscopes. The results of ...
... to review Intermezzo(R) (zolpidem tartrate sublingual lozenge) as the ... middle-of-the-night awakenings , , ... a privately-held specialty pharmaceutical company, announced today that it ... Administration (FDA) that the New Drug Application (NDA) for ...
... Dec. 16 Anesiva,Inc. (Nasdaq: ANSV ... Phase 3,trial evaluating Adlea(TM), its long-acting, non-opioid analgesic ... post-surgical,pain versus placebo (p=0.03) following total knee arthroplasty ... 48 hours after surgery. The trial also,met its ...
Cached Biology Technology:ASP Announces Availability of EVOTECH(TM) Endoscope Cleaner and Reprocessor - First Commercially Available System to Eliminate Manual Cleaning of Endoscopes 2Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R) 2Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R) 3Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R) 4Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R) 5Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery 2Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery 3Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery 4
(Date:12/11/2014)... Dec. 10, 2014  That blood pressure plays a role ... Hypertension – the medical term for high blood pressure – ... and the inflatable cuff that,s used in measuring blood pressure ... there,s nothing new about hypertension, its triggers and its effects. ... the condition and the best ways to treat it. ...
(Date:12/10/2014)... , Dec. 8, 2014 You,ve been here ... account but can,t remember your password, site key or the ... was your first grade teacher? Today, ... the app that will finally put an end to ... 1U TM . 1U leverages a user,s smartphone ...
(Date:12/10/2014)... 9, 2014  Wake Forest Baptist Medical Center today announced ... School of Medicine. Funding for this $50 million capital ... will be publicly launched next summer. ... former 60 series R.J. Reynolds Tobacco Company complex, adjacent ... begin immediately with plans to be ready to welcome ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... way to scan brain tumors and predict which ones will ... ever starts treatment. By linking high water movement in ... 70 percent accuracy which patients, tumors were the least likely ... considers himself lucky. When his aggressive brain cancer returned ...
... parts of living organisms come packaged with ribbons. The ... into three-dimensional structures to work properly. But when for ... happen, and in humans misfolded-protein disorders include Alzheimer,s and ... three decades tried to understand what makes proteins fold ...
... trees have declined in Yosemite National Park during the ... role. The number of large-diameter trees in the ... U.S. Geological Survey and University of Washington scientists compared ... to the most recent records from 1988�. A ...
Cached Biology News:A crystal ball for brain cancer? 2A crystal ball for brain cancer? 3New computer simulation helps explain folding in important cellular protein 2New computer simulation helps explain folding in important cellular protein 3
... Clean and Accurate Results Laser Capture ... the sensitivity and accuracy of molecular assays ... types and multi-cellular structures isolated from whole ... to microdissection-developed in 1996 at the National ...
... antibody raised against a partial ... Immunogen: ZFHX4 (NP_078997, 2 ... recombinant protein with GST tag. ... NM_024721 ...
... specificity and signaling of the members of ... modified by alternative splicing--which has important implications ... can perform a classical expression profiling and ... alternatively spliced forms of the gene that ...
... Alternative Splicing plays an important role in ... apoptosis and cell death. Splice variants have ... and inhibition of defined apoptotic pathways. With ... can perform a classical expression profiling and ...
Biology Products: